In vivo, 1H and 31P magnetic resonance spectroscopy were used to study human melanoma models to monitor the metabolic effects of dabrafenib therapy, an inhibitor of the hyperactive BRAF protein in melanoma. The gene discussed is BRAF; the disease is melanoma.